TP53 and cancer: It has been reported that PRIMA-1/PRIMA-1met selectively restores the sequence-specific DNA binding region of mutated p53 via forming adducts with thiols and recovers its normal wild-type function to induce apoptosis in cancer cells [17, 20, 21].